<DOC>
	<DOCNO>NCT02079727</DOCNO>
	<brief_summary>The purpose study confirm efficacy safety 800 mg Chondroitin 4 &amp; 6 sulfate ( Condrosulf ) v placebo day 6 month symptomatic treatment knee osteoarthritis . A third group , Celecoxib 200 mg ( Celebrex ) day , use active comparator .</brief_summary>
	<brief_title>Condrosulf v Celebrex v Placebo Treatment Knee OA</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Outpatients either sex , age ≥50 year Patients affect primary knee osteoarthritis medial lateral femorotibial compartment Diagnosis accord American College Rheumatology ( ACR ) criterion Kellgren &amp; Lawrence grade IIII Knee osteoarthritis evolve 6 month Patients suffer regular pain functional disorder least 3 month Accomplishing score ≥ 7 Lequesne 's index knee osteoarthritis Assessing pain Huskisson 's VAS ≥ 50 mm With radiography date less six month show remain articular joint space Without axial disorder justify osteotomy Women take contraceptive measure menopause Women negative pregnancy test Patients able understand follow study protocol Patients sign write informed consent participation clinical trial With history heart attack , ischemic heart disease cerebrovascular disease ( include transient ischemic attack ) Having peripheral arterial disease past surgery orf peripheral artery With history currently significat coagulation defect or/and blood dyscrasia With high risk cardiovascular event With acute chronic infection require antimicrobial therapy serious viral ( e.g. , hepatitis , HIV positivity ) fungal infection With history recurrent gastrointestinal ulceration active inflammatory bowel disease ( e.g. , Crohn 's disease ulcerative colitis ) Having diagnose treated oesophageal , gastric , pyloric channel , duodenal ulceration within 30 day prior receive first dose study medication Having severe liver kidney disease With allergy Celebrex ingredient Celebrex Having allergic reaction sulphonamides Having , result intake acetylsalicylic acid NSAIDs , asthma , nose polyp , severe nose congestion , allergic reaction itchy skin rash , swell face , lip , tongue throat , breathe difficulty wheeze Presenting lactose intolerance Mild symptomatic knee osteoarthritis : &lt; 7 Lequesne 's index , Pain Huskisson 's VAS ( Visual Analogic Scale ) &lt; 50 mm Predominantly femoropatellar osteoarthritis Destructive osteoarthritis knee justify surgery follow 6 month Osteoarthritis hydrarthrosis require puncture infiltration Important genu varum valgus &gt; 8° ( physiological angle include ) Kellgren &amp; Lawrence grade IV Knee joint surgery last 3 month ( e.g . chondroscopy , arthroscopy ) Viscosupplementation , tidal lavage last 6 month Arthritis metabolic arthropathy , Paget 's illness Having consume : basic treatment arthritis SYSADOA , symptomatic slow act drug osteoarthrithis ( chondroitin sulphate , glucosamine sulphate , diacerhein , hyaluronic acid food supplement joint care ) last 3 month ; treatment corticoid , administration route last month ; medication influence pain : NSAIDs ( nonsteroidal antiinflammatory drug ) 5 day precede inclusion ( washout period consider 5 halflives drug ) hypnotic , muscle relaxant , anxiolytic , intake start less 8 day inclusion paracetamol 10 hour precede inclusion Foreseen physiotherapy , reeducation , alternative medicine ( mesotherapy , acupuncture ) next six month ( study period ) Presenting psychiatric illness hinder protocol complaince , alcoholism , ongoing &lt; 1 year drug dependency Pregnant likely become clinical trial lactate Women positive pregnancy test Having participate clinical trial month precede clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Condrosulf</keyword>
	<keyword>Chondroitin sulfate</keyword>
	<keyword>Celebrex</keyword>
	<keyword>Knee OA</keyword>
	<keyword>Knee osteoarthritis</keyword>
</DOC>